GenEditBio Limited ("GenEditBio"), a clinical-stage biotechnology startup focusing on genome-editing therapeutic solutions, today announced that the U.S. Food and Drug Administration (FDA) has cleared ...
The US Food and Drug Administration (FDA) has cleared GenEditBio Limited’s Investigational New Drug (IND) application to ...
Finnish eyewear company IXI is gearing up to launch smart glasses that look just like ordinary spectacles, but are able to “autofocus” based on the perceived needs of the wearer.
BostonGene, the developer of the leading AI foundation model for tumor and immune biology, today announced a strategic collaboration with AstraZeneca, a global, science-led biopharmaceutical company ...
An update from Pharmaust Limited ( ($AU:NUZ) ) is now available. Neurizon Therapeutics has provided a regulatory update on NUZ-001, its ...
New members bring deep experience in pancreatic, colorectal, and anal cancers to guide pelareorep’s development as a platform immunotherapy across GI tumorsCompany continues to strengthen its clinical ...
Modern Engineering Marvels on MSN
Musk reveals 2026 push for automated Neuralink brain surgeries
Is the next great leap in human machine integration to come not from smartphones or AI chatbots, but from a coin-sized chip ...
Explore Intensive Outpatient Programs (IOPs), a flexible middle-ground care option that provides structured treatment while ...
Johnson & Johnson MedTech announced today that it submitted its Ottava surgical robotic system to the FDA for de novo ...
Stereotaxis plans to launch the MAGiC cardiac ablation catheter in early 2026, CEO and Chair David Fischel tells MassDevice.
Johnson & Johnson’s filing comes a month after Medtronic gained U.S. clearance for its Hugo system as competition in the soft ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback